Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Recipharm Pharmaceutical Development AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 120,071 Less Arrow 93,458 More Arrow 100,205
Financial expenses 2,906 Less Arrow 1,617 Less Arrow 302
Earnings before taxes 9,755 Less Arrow -8,059 More Arrow -6,431
EBITDA 13,588 Less Arrow -4,546 More Arrow -2,601
Total assets 65,801 Less Arrow 49,019 More Arrow 63,385
Current assets 49,810 Less Arrow 30,909 More Arrow 46,991
Current liabilities 32,738 Less Arrow 22,128 More Arrow 29,946
Equity capital 33,063 Less Arrow 26,891 More Arrow 33,439
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 69 Less Arrow 62 More Arrow 64

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% More Arrow 54.9% Less Arrow 52.8%
Turnover per employee 1,740 Less Arrow 1,507 More Arrow 1,566
Profit as a percentage of turnover 8.1% Less Arrow -8.6% More Arrow -6.4%
Return on assets (ROA) 19.2% Less Arrow -13.1% More Arrow -9.7%
Current ratio 152.1% Less Arrow 139.7% More Arrow 156.9%
Return on equity (ROE) 29.5% Less Arrow -30.0% More Arrow -19.2%
Change turnover 26,613 Less Arrow -6,747 More Arrow -3,621
Change turnover % 28% Less Arrow -7% More Arrow -3%
Chg. No. of employees 7 Less Arrow -2 More Arrow 3
Chg. No. of employees % 11% Less Arrow -3% More Arrow 5%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.